Viyash Scientific AGM: All resolutions passed, including director re-appointments and AoA adoption.
Viyash Scientific Limited's AGM on August 11, 2026, saw all resolutions pass. Key approvals include audited financial statements for FY26, re-appointments of directors Dr. Haribabu Bodepudi and Mr. Rajaram Narayanan, and adoption of a new Articles of Association. Cost Auditor remuneration was also ratified for FY26 and FY27.
The passing of resolutions related to director re-appointments and adoption of new Articles of Association are important for corporate governance and operational continuity. While routine, they signal stability.
All resolutions were passed with a requisite majority, indicating shareholder approval and confidence in the company's proposed actions and leadership.
Viyash Scientific Limited (formerly Sequent Scientific Limited) announced that all resolutions presented at its Forty-First Annual General Meeting (AGM), held on August 11, 2026, were duly passed by the members with the requisite majority through remote e-voting and e-voting at the AGM. The resolutions included the adoption of audited financial statements for the financial year ended March 31, 2026, the re-appointment of directors Dr. Haribabu Bodepudi and Mr. Rajaram Narayanan, ratification of revised remuneration for the Cost Auditor for FY 2025-2026 and for FY 2026-2027, and the adoption of a new set of Articles of Association.
The Notice for the AGM was dated May 19, 2026. The remote e-voting period commenced on August 7, 2026, and concluded on August 10, 2026. The cut-off date for voting entitlement was August 4, 2026.
The company also submitted the voting results as per Regulation 44 of SEBI Listing Regulations and a Consolidated Scrutinizer’s Report dated August 11, 2026.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.